Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP288273.RAxdiVyH-kWJF9s61AbMi1XxGCDgmhi2Qik5YCDNEjr3A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP288273.RAxdiVyH-kWJF9s61AbMi1XxGCDgmhi2Qik5YCDNEjr3A130_assertion type Assertion NP288273.RAxdiVyH-kWJF9s61AbMi1XxGCDgmhi2Qik5YCDNEjr3A130_head.
- NP288273.RAxdiVyH-kWJF9s61AbMi1XxGCDgmhi2Qik5YCDNEjr3A130_assertion description "[Analyses delineated four ovarian cancer transcriptional subtypes, three microRNA subtypes, four promoter methylation subtypes and a transcriptional signature associated with survival duration, and shed new light on the impact that tumours with BRCA1/2 (BRCA1 or BRCA2) and CCNE1 aberrations have on survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288273.RAxdiVyH-kWJF9s61AbMi1XxGCDgmhi2Qik5YCDNEjr3A130_provenance.
- NP288273.RAxdiVyH-kWJF9s61AbMi1XxGCDgmhi2Qik5YCDNEjr3A130_assertion evidence source_evidence_literature NP288273.RAxdiVyH-kWJF9s61AbMi1XxGCDgmhi2Qik5YCDNEjr3A130_provenance.
- NP288273.RAxdiVyH-kWJF9s61AbMi1XxGCDgmhi2Qik5YCDNEjr3A130_assertion SIO_000772 21720365 NP288273.RAxdiVyH-kWJF9s61AbMi1XxGCDgmhi2Qik5YCDNEjr3A130_provenance.
- NP288273.RAxdiVyH-kWJF9s61AbMi1XxGCDgmhi2Qik5YCDNEjr3A130_assertion wasDerivedFrom befree-20150227 NP288273.RAxdiVyH-kWJF9s61AbMi1XxGCDgmhi2Qik5YCDNEjr3A130_provenance.
- NP288273.RAxdiVyH-kWJF9s61AbMi1XxGCDgmhi2Qik5YCDNEjr3A130_assertion wasGeneratedBy ECO_0000203 NP288273.RAxdiVyH-kWJF9s61AbMi1XxGCDgmhi2Qik5YCDNEjr3A130_provenance.